Glutamate (ampa/kainate) receptor antagonists: N-substituted fused azacycloalkylquinoxalinediones
US6197771A · kind A · utility
7Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2000 |
| Grant date | Mar 6, 2001 |
| Priority date | — |
| Expiry date | Feb 7, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D217/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel N-substituted azacycloalkyl ring fused 2,3-quinoxalinediones represented by the formula: ##STR1## or a pharmaceutically acceptable salt thereof, are disclosed, wherein the formula variables R.sup.1, R.sup.2, X, Y, m and n are as defined herein. Also disclosed are methods of treatment using the same and intermediate compounds useful in the preparation thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.